$1–$10 Watch: 10 Stocks That Could Explode — October 12, 2026

Introduction In the world of speculative trading, stocks priced between $1 and $10 often present unique opportunities for outsized returns. These stocks may be volatile and high-risk, but they also come with significant upside potential. This article analyzes ten stocks in this price range that could explode in the coming months.

1. SNDL - Sundial Growers Inc. - **Current Price:** $2.45 - **Sector:** Cannabis - **Volume Profile:** Increasing volume over the last month indicates accumulation. - **Short Interest:** Approximately 20% of the float is shorted, presenting a potential short squeeze. - **Catalyst:** Expanding into the U.S. market with new product lines could drive growth. - **Technical Setup:** Currently bouncing off support at $2.20, showing bullish momentum. - **Risk Factors:** Regulatory hurdles in the cannabis sector are a concern. - **Bull Case Price Target:** $4.00 (30-90 days) - **Risk Rating:** 🟡 High

2. CLOV - Clover Health Investments Corp. - **Current Price:** $3.10 - **Sector:** Health Insurance - **Volume Profile:** Steady increase in volume suggests investor interest. - **Short Interest:** Around 40% short interest creates potential for a squeeze. - **Catalyst:** Upcoming earnings report could provide positive surprises. - **Technical Setup:** Consolidating around the $3.00 level, poised for a breakout. - **Risk Factors:** Competitive pressures in the health insurance market. - **Bull Case Price Target:** $5.00 (30-90 days) - **Risk Rating:** 🟡 High

3. MVIS - MicroVision Inc. - **Current Price:** $4.50 - **Sector:** Technology - **Volume Profile:** Noticeable accumulation over the past two weeks. - **Short Interest:** Approximately 18% short interest, indicating some potential squeeze. - **Catalyst:** New contracts in automotive LIDAR technology could drive demand. - **Technical Setup:** Recently broke above resistance at $4.30, signaling bullish trends. - **Risk Factors:** Dependence on a niche technology market poses a risk. - **Bull Case Price Target:** $6.50 (30-90 days) - **Risk Rating:** 🟢 Moderate

4. ZOM - Zomedica Corp. - **Current Price:** $0.95 - **Sector:** Veterinary Medicine - **Volume Profile:** Volume has surged in recent weeks, indicating growing interest. - **Short Interest:** Short interest is around 25%, creating squeeze potential. - **Catalyst:** Launch of a new diagnostic product for pets could drive revenue growth. - **Technical Setup:** Bouncing off critical support at $0.90. - **Risk Factors:** Limited product pipeline could hinder long-term growth. - **Bull Case Price Target:** $1.50 (30-90 days) - **Risk Rating:** 🔴 Very High

5. AITX - Artificial Intelligence Technology Solutions Inc. - **Current Price:** $1.20 - **Sector:** Security Technology - **Volume Profile:** Increasing volume suggests accumulation. - **Short Interest:** Approximately 30% short interest, indicating potential for a squeeze. - **Catalyst:** New contracts for AI-driven security solutions could increase revenue. - **Technical Setup:** Testing resistance at $1.25, with bullish momentum. - **Risk Factors:** Highly speculative nature of AI technology poses risks. - **Bull Case Price Target:** $2.00 (30-90 days) - **Risk Rating:** 🟡 High

6. BIOC - Bioceres Crop Solutions Corp. - **Current Price:** $6.80 - **Sector:** Agriculture - **Volume Profile:** Volume has been increasing steadily, indicating accumulation. - **Short Interest:** Around 10%, lower than some peers, less squeeze potential. - **Catalyst:** Upcoming product launches in sustainable agriculture could boost sales. - **Technical Setup:** Recently broke out of a consolidation pattern. - **Risk Factors:** Dependence on agricultural commodity prices. - **Bull Case Price Target:** $9.00 (30-90 days) - **Risk Rating:** 🟢 Moderate

7. HCMC - Healthier Choices Management Corp. - **Current Price:** $0.005 - **Sector:** Health & Wellness - **Volume Profile:** Recently saw a spike in volume, suggesting renewed interest. - **Short Interest:** Not widely reported but generally low, indicating less risk of a squeeze. - **Catalyst:** Potential partnerships for smokeless products could drive growth. - **Technical Setup:** Testing support around $0.005, could bounce back. - **Risk Factors:** Business model viability in a competitive market. - **Bull Case Price Target:** $0.01 (30-90 days) - **Risk Rating:** 🔴 Very High

8. OCGN - Ocugen Inc. - **Current Price:** $2.10 - **Sector:** Biotechnology - **Volume Profile:** Increasing volume indicates accumulation. - **Short Interest:** Approximately 15% of the float is shorted, moderate squeeze potential. - **Catalyst:** FDA approval for COVID-19 vaccine could lead to significant upside. - **Technical Setup:** Approaching resistance at $2.20, potential breakout. - **Risk Factors:** Regulatory setbacks could hinder growth. - **Bull Case Price Target:** $3.50 (30-90 days) - **Risk Rating:** 🟡 High

9. TTOO - T2 Biosystems Inc. - **Current Price:** $1.50 - **Sector:** Medical Devices - **Volume Profile:** Volume has increased significantly in recent weeks. - **Short Interest:** Approximately 20%, indicating squeeze potential. - **Catalyst:** New product launches in rapid diagnostics could enhance growth. - **Technical Setup:** Breaking above key resistance at $1.40. - **Risk Factors:** Competition from established players in diagnostics. - **Bull Case Price Target:** $2.50 (30-90 days) - **Risk Rating:** 🟡 High

10. TGRW - TeraWulf Inc. - **Current Price:** $3.50 - **Sector:** Renewable Energy - **Volume Profile:** Increased volume indicates institutional interest. - **Short Interest:** About 12%, lower short interest reduces squeeze potential. - **Catalyst:** Expansion into new renewable energy projects could drive growth. - **Technical Setup:** Testing resistance around $3.60. - **Risk Factors:** Regulatory changes in energy policies could pose risks. - **Bull Case Price Target:** $5.00 (30-90 days) - **Risk Rating:** 🟢 Moderate

Why These Price Ranges Matter Low-float, low-price stocks often have mechanical advantages that can lead to rapid price movements. These stocks are typically less liquid, which means that even small buying or selling can cause significant price fluctuations. Additionally, the lower price point makes them accessible to a broader range of retail investors, increasing trading volume during speculative frenzies.

How to Trade Them Safely When trading low-priced stocks, it’s critical to manage risk through careful position sizing. Limit orders can help protect against unexpected volatility. Monitoring catalysts, such as earnings reports or regulatory announcements, can also provide strategic entry points. Establishing stop-loss orders is essential to limit potential losses.

Catalyst Calendar - **CLOV:** Earnings report expected on October 20, 2026 - **SNDL:** New product line announcement on November 5, 2026 - **OCGN:** FDA decision expected on November 15, 2026

Investors should remain vigilant and conduct their own research before making investment decisions. The stocks listed here represent high-risk speculative plays that require diligent risk management strategies.

Educational content only. Not financial advice. DYOR.